Key facts
- VM Agritech’s last known valuation is $218.0M (Nov 2025).
- It has raised $36.1M across 3 recorded rounds; the latest was Early Stage VC ($17.6M) in Nov 2025.
- Notable investors include DeltaCap, University of Exeter.
- VM Agritech has filed 2 Form Ds with the SEC since 2024, most recently Mar 2025 ($11.0M sold to 25 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for VM Agritech
Funding rounds
3 roundsAbout VM Agritech
Developer of a copper-based liquid fungicide designed to fight fungal resistance on a broad-spectrum basis in both row and specialty crops. The company uses the effective compound citizen to protect crop yields from pathogens, enabling agricultural companies to fight against pathogenic resistance.
- Sector
- Materials and Resources
- HQ
- Geneva, NY, United States
- Founded
- 2014
- Employees
- 20
- Website
- vmagritech.com/
- Ownership
- Privately Held (backing)
VM Agritech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VM Agritech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VM Agritech in its N-PORT filings yet. We sweep new filings monthly.